Growth Metrics

Oncology Institute (TOI) Acquisitions (2021 - 2023)

Oncology Institute's Acquisitions history spans 3 years, with the latest figure at $156000.0 for Q4 2023.

  • For Q4 2023, Acquisitions fell 66.81% year-over-year to $156000.0; the TTM value through Dec 2024 reached $156000.0, up 183.42%, while the annual FY2023 figure was $4.5 million, 48.05% down from the prior year.
  • Acquisitions reached $156000.0 in Q4 2023 per TOI's latest filing, down from $470000.0 in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $8.9 million in Q2 2022 to a low of -$813000.0 in Q3 2022.
  • Average Acquisitions over 3 years is $3.0 million, with a median of $648500.0 recorded in 2021.
  • Peak YoY movement for Acquisitions: tumbled 94.32% in 2022, then plummeted 66.81% in 2023.
  • A 3-year view of Acquisitions shows it stood at $8.3 million in 2021, then crashed by 94.32% to $470000.0 in 2022, then tumbled by 66.81% to $156000.0 in 2023.
  • Per Business Quant, the three most recent readings for TOI's Acquisitions are $156000.0 (Q4 2023), $470000.0 (Q4 2022), and -$813000.0 (Q3 2022).